Exploring the critical second genetic event that transforms BRCA susceptibility into breast cancer malignancy, with insights into mechanisms, clinical implications, and future research directions.
Breakthrough research on zenocutuzumab, a bispecific antibody targeting NRG1 fusion-positive cancers, with results from the eNRGy trial showing promising outcomes across multiple tumor types.
Discover how GO-2D reveals 2-dimensional functional modules in cells by mapping protein interactions to specific cellular locations and molecular functions.
Understanding immune-mediated toxicities in MDS patients treated with nivolumab and ipilimumab, including mechanisms, clinical patterns, and management strategies.
Discover how circular RNAs (circRNAs) are revolutionizing plant stress resistance and offering new hope for climate-resilient agriculture.
Exploring how machine learning is revolutionizing our understanding of TERT expression in cancer cells and its implications for precision oncology.
Discover how CRISPR systems like Cas13 and Cas12a are transforming disease detection with SHERLOCKv2 technology, enabling portable, multiplexed nucleic acid diagnostics.
Exploring how nano-biointerfaces are overcoming biological barriers to revolutionize drug delivery systems
Discover how the RISK system uses machine learning to predict venous thromboembolism in cancer patients with unprecedented accuracy.
Exploring how radiation biomarkers are transforming cancer treatment, space travel safety, and disaster response through cutting-edge molecular diagnostics.